Chicago, ILCIK 12744034 filings on record
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeLargest positions by weight
9 positions · Q4 2025
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Maze Therapeutics Inc | 4.12M | $170.69M | 26.2% | 0 | Held |
| 2 | Beam Therapeutics Inc | 4.54M | $125.85M | 19.3% | 0 | Held |
| 3 | Rapport Therapeutics Inc | 3.73M | $113.13M | 17.4% | 0 | Held |
| 4 |
| 2.76M |
| $84.92M |
| 13.0% |
| 0 |
| Held |
| 5 | Vir Biotechnology Inc | 12.92M | $77.89M | 12.0% | 0 | Held |
| 6 | Erasca Inc | 11.06M | $41.13M | 6.3% | 0 | Held |
| 7 | Gossamer Bio Inc | 8.06M | $24.97M | 3.8% | 0 | Held |
| 8 | 10x Genomics Inc | 737.5K | $12.03M | 1.8% | +737.5K | New |
| 9 | Q32 Bio Inc | 320.5K | $1.06M | 0.2% | 0 | Held |